Riskpilot← Back to searchSign inGet full accessGyn. Mottagning E. Svanborg AB
ABActiveOrg 5565296877Centralvägen 17Medical specialists activities · NACE 8622Est. 19962 employees
Revenue 2024
SEK 4,1M
-2% vs 2023
EBITDA margin
10.2%
-77% vs 2023
Equity ratio
71.5%
Financial strength
Net profit 2024
SEK 1M
-66% vs 2023
| Revenue | SEK 4,1M | -2% |
| EBITDA | SEK 419K | -77% |
| Net profit | SEK 1M | -66% |
| Total assets | SEK 6M | -9% |
| Equity | SEK 4,3M | +1% |
| Employees | 2 | — |
Legal name
Gyn. Mottagning E. Svanborg AB
Org number
5565296877
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
4 mars 1996
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva läkarmottagning och därmed förenlig verksamhet.
Address
Centralvägen 17
Email
gyn.svanborg@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 4 052 | 3 616 | 3 670 | 3 916 | 3 803 | 4 216 | 4 112 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 1 065 | 833 | 10 611 | 970 | −118 | −48 | 217 | 791 | 1 822 | 419 |
| Depreciation & amort. | −205 | −196 | −91 | −91 | −39 | −190 | −189 | −189 | −190 | −182 |
| EBIT | 860 | 637 | 10 520 | 879 | −157 | −238 | 28 | 602 | 1 632 | 237 |
| Net financials | −157 | −114 | 350 | −8 | −16 | −29 | −21 | −23 | 668 | 769 |
| Profit before tax | 493 | 373 | 8 561 | 827 | 89 | 68 | 6 | 478 | 3 783 | 1 126 |
| Tax | −148 | −103 | −1 595 | −186 | −25 | −56 | −4 | −102 | −672 | −80 |
| Net profit | 345 | 270 | 6 966 | 641 | 64 | 12 | 2 | 376 | 3 111 | 1 046 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 6 735 | 0 | 12 416 | 9 654 | 8 104 | 6 791 | 5 817 | 6 185 | 6 586 | 5 986 |
| Equity | 675 | 696 | 7 161 | 4 603 | 3 867 | 3 079 | 2 381 | 2 058 | 4 219 | 4 282 |
| Long-term debt | 4 245 | 4 356 | 154 | 112 | 596 | 480 | 91 | 1 029 | 372 | 0 |
| Short-term debt | 195 | 341 | 1 832 | 1 628 | 592 | 517 | 629 | 284 | 663 | 492 |
| Total debt | 4 440 | 4 697 | 1 986 | 1 740 | 1 188 | 997 | 720 | 1 313 | 1 035 | 492 |
EBITDA margin
10.2%
This company
15.8%
Market median
-35% vs market
20152024
Equity ratio
71.5%
This company
38.2%
Market median
+87% vs market
20152024
Return on equity
24.4%
This company
18.4%
Market median
+33% vs market
20152024
Net profit margin
25.4%
This company
8.1%
Market median
+214% vs market
20152024
Asset turnover
0.69×
This company
1.12×
Market median
-38% vs market
20152024
Debt / equity
0.40×
This company
0.62×
Market median
+35% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
GK Auditor Substitute | Auditor Substitute | 2020 | — | — |
NG | Audit | 2020 | — | — |
TS Auditor Substitute | Auditor Substitute | 2020 | — | — |
| Audit | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2021 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Board of Directors | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Gyn. Mottagning E. Svanborg AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gunborg Kristina Johansson | Auditor Substitute | 0 companies |
| Nils Gösta Linderfalk | Audit | 0 companies |
| Tuuli Sylvia Ceamanos | Auditor Substitute | 0 companies |
| Eric Peter Hilding Hasselgren | Audit | 0 companies |
| Martin Jonas Svanborg Östlin | Deputy Board Member | 0 companies |
| Beatrice Fejde | Deputy Board Member | 0 companies |
| Eva Märta Kristina Svanborg | Board of Directors | 0 companies |